Skip to main content

Advertisement

You are viewing the new article page. Let us know what you think. Return to old version

Erratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence

The original article was published in Breast Cancer Research 2014 16:3417

Erratum

During the editorial process preceding the publication of this article an error was introduced in the heading of “Table 1 Univariate and multivariate analysis of elafin-positive cells in breast cancer patients.” This error was only noticed after publication of the final version. Specifically, both data-containing columns are labeled “Elafin Negative.” The data-containing column on the right should in fact be labeled “Elafin Positive (n = 482).” The corrected version can be found here (Table 1). Table 1 has also been updated in the original article to reflect the correct labeling of the columns.

Table 1 Univariate and multivariate analysis of elafin-positive cells in breast cancer patients

References

  1. 1.

    Caruso JA, Karakas C, Zhang J, Yi M, Albarracin C, Sahin A, et al. Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence. Breast Canc Res. 2014;16:3417.

Download references

Author information

Correspondence to Khandan Keyomarsi.

Additional information

The online version of the original article can be found under doi:10.1186/s13058-014-0497-4.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark